EcoDrugPlus

High Mobility Group Protein B1-Like

Ensembl ID : ENSAMXG00000031365
Gene Symbol: LOC103041093
3 Cross references
510 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSAMXG00000029194
Gene Symbol: LOC103039534
3 Cross references
454 Possible Orthologues:

Histamine H2 Receptor-Like

Ensembl ID : ENSAMXG00000016195
Gene Symbol: LOC103036158
3 Cross references
192 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSAMXG00000025040
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSAMXG00000032087
Gene Symbol: HRH2
4 Cross references
181 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSAMXG00000015539
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSAMXG00000034575
Gene Symbol: HDAC11
3 Cross references
200 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSAMXG00000014325
Gene Symbol: HDAC2
4 Cross references
205 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSAMXG00000042915
Gene Symbol: HDAC3
2 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSAMXG00000013400
Gene Symbol: HDAC4
1 Cross references
196 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSAMXG00000018271
Gene Symbol: HDAC4
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSAMXG00000000390
Gene Symbol: HDAC5
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).